版本:
中国

BRIEF-Zynerba Pharmaceuticals reports Q1 loss per share $0.60

May 9 Zynerba Pharmaceuticals Inc:

* Zynerba Pharmaceuticals reports first quarter 2017 financial results and operational highlights

* Q1 loss per share $0.60

* Q1 earnings per share view $-0.55 -- Thomson Reuters I/B/E/S

* Zynerba Pharmaceuticals Inc - believes that current cash position of $77.5 million is sufficient to fund operations and capital requirements into 2019 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐